Summary
Rachel Faye Smith will speak at Marsh & McLennan Agency's "Leaders in Life Science Networking Event: Retirement Plan Trends."
Speakers
- /en/people/s/smith-rachel-faye
Rachel Faye Smith
Partner
Related Content
- InsightMay 28, 2024
A Token of Appreciation: Cryptoassets and Employee Incentives — a UK Tax Primer
- AlertApril 26, 2024
DOL Issues New Rule Raising Minimum Salary Thresholds for Overtime Exemptions
- AlertApril 9, 2024
The Department of Labor Finalizes Changes to the QPAM Exemption – A Favored Management Tool Gets Less User-Friendly
- AlertJanuary 10, 2024
Deadline Approaching for Reporting 2023 ISO Exercises and ESPP Transfers
- AlertDecember 29, 2023
Rushing to Chaos: The U.S. Department of Labor’s Well-Intentioned, Yet Unworkable Proposal to Redefine Fiduciary Investment Advice
- InsightJuly 19, 2023
ERISA Litigation Update
- AlertApril 19, 2023
A Step Towards Guidance Instead of Regulation by Litigation in the ESOP Space
- InsightApril 11, 2023
ERISA Litigation Update
- Awards and RankingsJune 13, 2024
The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 187 Lawyers
- Press ReleaseJune 13, 2024
Rapport Therapeutics Completes $174.4 Millon Initial Public Offering and Concurrent Private Placement
- Awards and RankingsJune 6, 2024
Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service
- Press ReleaseMay 29, 2024
Akili Interactive to Be Acquired by Virtual Therapeutics
- Press ReleaseMay 22, 2024
Human Immunology Biosciences to be Acquired by Biogen For $1.15 Billion Upfront and up to $650 Million in Potential Milestone Payments
- Press ReleaseMay 17, 2024
Proteologix to be Acquired by Johnson & Johnson For $850 Million
- Press ReleaseMay 9, 2024
Royalty Pharma To Acquire Royalty Interest In ImmuNext’s Frexalimab
- Press ReleaseMay 2, 2024
Mariana Oncology To Be Acquired by Novartis For $1 Billion Upfront, And Up To $750 Million in Milestones